KRTX — Karuna Therapeutics Share News
0.000.00%
Last trade - 00:00- $12.58bn
- $11.32bn
- $0.65m
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)
Bristol Myers posts better-than-expected 4th-quarter results
What to Watch in the Day Ahead - Friday, February 2
What to Watch in the Week Ahead and on Monday, January 29
U.S. RESEARCH ROUNDUP- Cerevel Therapeutics, Cytokinetics, Karuna Therapeutics
U.S. RESEARCH ROUNDUP-Aspen Aerogels, Daseke, Karuna Therapeutics
Brief: Bristol-Myers Squibb Will Be Required To Pay Karuna Therapeutics Fee Of $600 mln If Deal Terminated
US STOCKS-S&P 500 ends higher ahead of long holiday weekend
US STOCKS-S&P 500 ends higher ahead of long holiday weekend
US STOCKS-Wall Street turns negative ahead of long holiday weekend
Newscasts - Trading at Noon: Wall St rises after soft inflation data
Karuna jumps on $14 bln buyout by Bristol Myers in last minute Christmas shopping
Bristol Myers new CEO grabs M&A by the horns
Karuna jumps on $14 bln buyout by Bristol Myers in last minute Christmas shopping
U.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
Deals of the day-Mergers and acquisitions